APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antimicrobial Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Antimicrobial Therapeutics Market Analysis and Forecast 2026-2032

22 December 2025192 pages

Choose your research edition.

Industry ResearchAntimicrobial Therapeutics Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Antimicrobial Therapeutics Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Antimicrobial Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antimicrobial Therapeutics Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Antimicrobial Therapeutics Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Antimicrobial Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Antimicrobial Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antimicrobial Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antimicrobial Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antimicrobial Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Antimicrobial Therapeutics include Sanofi, Merck & Co Inc., Pfizer Inc., GlaxoSmithKline plc and Gilead Sciences, Inc., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Antimicrobial Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antimicrobial Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Antimicrobial Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antimicrobial Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antimicrobial Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Antimicrobial Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Antimicrobial Therapeutics Segment by Company

Sanofi

Merck & Co Inc.

Pfizer Inc.

GlaxoSmithKline plc

Gilead Sciences, Inc.

Antimicrobial Therapeutics Segment by Type

Personal

Hospital

Clinic

Other

Antimicrobial Therapeutics Segment by Application

Antifungal

Antibacterial

Antiparasitic

Antiviral

Antimicrobial Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antimicrobial Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antimicrobial Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antimicrobial Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Antimicrobial Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Antimicrobial Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antimicrobial Therapeutics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antimicrobial Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Personal Major Player Table 3. Hospital Major Player Table 4. Clinic Major Player Table 5. Other Major Player Table 6. Global Antimicrobial Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Antifungal Major Player Table 8. Antibacterial Major Player Table 9. Antiparasitic Major Player Table 10. Antiviral Major Player Table 11. Antimicrobial Therapeutics Industry Trends Table 12. Antimicrobial Therapeutics Industry Drivers Table 13. Antimicrobial Therapeutics Industry Opportunities and Challenges Table 14. Antimicrobial Therapeutics Industry Restraints Table 15. Global Antimicrobial Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Antimicrobial Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Antimicrobial Therapeutics Market Share by Region (2021-2026) Table 18. Global Antimicrobial Therapeutics Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Antimicrobial Therapeutics Market Share by Region (2027-2032) Table 20. Global Antimicrobial Therapeutics Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Antimicrobial Therapeutics Revenue Market Share by Players (2021-2026) Table 22. Global Antimicrobial Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Antimicrobial Therapeutics Key Players Headquarters & Area Served Table 24. Global Antimicrobial Therapeutics Players, Product Type & Application Table 25. Global Antimicrobial Therapeutics Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Antimicrobial Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Antimicrobial Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Antimicrobial Therapeutics Revenue Market Share by Type (2021-2026) Table 32. Global Antimicrobial Therapeutics Revenue Market Share by Type (2027-2032) Table 33. Global Antimicrobial Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Antimicrobial Therapeutics Revenue Market Share by Application (2021-2026) Table 37. Global Antimicrobial Therapeutics Revenue Market Share by Application (2027-2032) Table 38. Sanofi Company Information Table 39. Sanofi Business Overview Table 40. Sanofi Antimicrobial Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Sanofi Antimicrobial Therapeutics Product Portfolio Table 42. Sanofi Recent Development Table 43. Merck & Co Inc. Company Information Table 44. Merck & Co Inc. Business Overview Table 45. Merck & Co Inc. Antimicrobial Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Merck & Co Inc. Antimicrobial Therapeutics Product Portfolio Table 47. Merck & Co Inc. Recent Development Table 48. Pfizer Inc. Company Information Table 49. Pfizer Inc. Business Overview Table 50. Pfizer Inc. Antimicrobial Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Pfizer Inc. Antimicrobial Therapeutics Product Portfolio Table 52. Pfizer Inc. Recent Development Table 53. GlaxoSmithKline plc Company Information Table 54. GlaxoSmithKline plc Business Overview Table 55. GlaxoSmithKline plc Antimicrobial Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. GlaxoSmithKline plc Antimicrobial Therapeutics Product Portfolio Table 57. GlaxoSmithKline plc Recent Development Table 58. Gilead Sciences, Inc. Company Information Table 59. Gilead Sciences, Inc. Business Overview Table 60. Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Gilead Sciences, Inc. Antimicrobial Therapeutics Product Portfolio Table 62. Gilead Sciences, Inc. Recent Development Table 63. North America Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 66. North America Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 67. North America Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 68. North America Antimicrobial Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 69. North America Antimicrobial Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 70. Europe Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 71. Europe Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 72. Europe Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 73. Europe Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 74. Europe Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. Europe Antimicrobial Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Antimicrobial Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 77. China Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 78. China Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 79. China Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 80. China Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 81. Asia Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 82. Asia Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 83. Asia Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 84. Asia Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 85. Asia Antimicrobial Therapeutics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 86. Asia Antimicrobial Therapeutics Revenue by Region (US$ Million) & (2021-2026) Table 87. Asia Antimicrobial Therapeutics Revenue by Region (US$ Million) & (2027-2032) Table 88. SAMEA Antimicrobial Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 89. SAMEA Antimicrobial Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 90. SAMEA Antimicrobial Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 91. SAMEA Antimicrobial Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 92. SAMEA Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. SAMEA Antimicrobial Therapeutics Revenue by Country (2021-2026) & (US$ Million) Table 94. SAMEA Antimicrobial Therapeutics Revenue by Country (US$ Million) & (2027-2032) Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Antimicrobial Therapeutics Image Figure 2. Global Antimicrobial Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antimicrobial Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Personal Image Figure 5. Hospital Image Figure 6. Clinic Image Figure 7. Other Image Figure 8. Global Antimicrobial Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Antimicrobial Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 10. Antifungal Image Figure 11. Antibacterial Image Figure 12. Antiparasitic Image Figure 13. Antiviral Image Figure 14. Global Antimicrobial Therapeutics Market Size (US$ Million) & (2021-2032) Figure 15. Global Antimicrobial Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Antimicrobial Therapeutics Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Antimicrobial Therapeutics Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Antimicrobial Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Antimicrobial Therapeutics Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Antimicrobial Therapeutics Revenue Market Share by Type (2021-2032) Figure 22. Global Antimicrobial Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Antimicrobial Therapeutics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Antimicrobial Therapeutics Revenue Market Share by Application (2021-2032) Figure 25. North America Antimicrobial Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Antimicrobial Therapeutics Revenue Share by Type (2021-2032) Figure 27. North America Antimicrobial Therapeutics Revenue Share by Application (2021-2032) Figure 28. North America Antimicrobial Therapeutics Revenue Share by Country (2021-2032) Figure 29. United States Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Antimicrobial Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Antimicrobial Therapeutics Revenue Share by Type (2021-2032) Figure 34. Europe Antimicrobial Therapeutics Revenue Share by Application (2021-2032) Figure 35. Europe Antimicrobial Therapeutics Revenue Share by Country (2021-2032) Figure 36. Germany Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Antimicrobial Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Antimicrobial Therapeutics Revenue Share by Type (2021-2032) Figure 46. China Antimicrobial Therapeutics Revenue Share by Application (2021-2032) Figure 47. Asia Antimicrobial Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Antimicrobial Therapeutics Revenue Share by Type (2021-2032) Figure 49. Asia Antimicrobial Therapeutics Revenue Share by Application (2021-2032) Figure 50. Asia Antimicrobial Therapeutics Revenue Share by Region (2021-2032) Figure 51. Japan Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Antimicrobial Therapeutics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Antimicrobial Therapeutics Revenue Share by Type (2021-2032) Figure 59. SAMEA Antimicrobial Therapeutics Revenue Share by Application (2021-2032) Figure 60. SAMEA Antimicrobial Therapeutics Revenue Share by Country (2021-2032) Figure 61. Brazil Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Antimicrobial Therapeutics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Personal
  • Hospital
  • Clinic
  • Other
Applications
  • Antifungal
  • Antibacterial
  • Antiparasitic
  • Antiviral
Companies covered
  • Sanofi
  • Merck & Co Inc.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Gilead Sciences, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antimicrobial Therapeutics Market by Type
  3. 1.2.1 Global Antimicrobial Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Personal
  5. 1.2.3 Hospital
  6. 1.2.4 Clinic
  7. 1.2.5 Other
  8. 1.3 Antimicrobial Therapeutics Market by Application
  9. 1.3.1 Global Antimicrobial Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Antifungal
  11. 1.3.3 Antibacterial
  12. 1.3.4 Antiparasitic
  13. 1.3.5 Antiviral
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Antimicrobial Therapeutics Market Dynamics
  1. 2.1 Antimicrobial Therapeutics Industry Trends
  2. 2.2 Antimicrobial Therapeutics Industry Drivers
  3. 2.3 Antimicrobial Therapeutics Industry Opportunities and Challenges
  4. 2.4 Antimicrobial Therapeutics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Antimicrobial Therapeutics Market Perspective (2021-2032)
  2. 3.2 Global Antimicrobial Therapeutics Growth Trends by Region
  3. 3.2.1 Global Antimicrobial Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antimicrobial Therapeutics Market Size by Region (2021-2026)
  5. 3.2.3 Global Antimicrobial Therapeutics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Antimicrobial Therapeutics Revenue by Players
  2. 4.1.1 Global Antimicrobial Therapeutics Revenue by Players (2021-2026)
  3. 4.1.2 Global Antimicrobial Therapeutics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Antimicrobial Therapeutics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antimicrobial Therapeutics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Antimicrobial Therapeutics Key Players Headquarters & Area Served
  7. 4.4 Global Antimicrobial Therapeutics Players, Product Type & Application
  8. 4.5 Global Antimicrobial Therapeutics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Antimicrobial Therapeutics Market CR5 and HHI
  11. 4.6.3 2025 Antimicrobial Therapeutics Tier 1, Tier 2, and Tier 3
5 Antimicrobial Therapeutics Market Size by Type
  1. 5.1 Global Antimicrobial Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 5.3 Global Antimicrobial Therapeutics Revenue Market Share by Type (2021-2032)
6 Antimicrobial Therapeutics Market Size by Application
  1. 6.1 Global Antimicrobial Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Antimicrobial Therapeutics Revenue by Application (2021-2032)
  3. 6.3 Global Antimicrobial Therapeutics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Antimicrobial Therapeutics Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck & Co Inc.
  8. 7.2.1 Merck & Co Inc. Company Information
  9. 7.2.2 Merck & Co Inc. Business Overview
  10. 7.2.3 Merck & Co Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Merck & Co Inc. Antimicrobial Therapeutics Product Portfolio
  12. 7.2.5 Merck & Co Inc. Recent Developments
  13. 7.3 Pfizer Inc.
  14. 7.3.1 Pfizer Inc. Company Information
  15. 7.3.2 Pfizer Inc. Business Overview
  16. 7.3.3 Pfizer Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Inc. Antimicrobial Therapeutics Product Portfolio
  18. 7.3.5 Pfizer Inc. Recent Developments
  19. 7.4 GlaxoSmithKline plc
  20. 7.4.1 GlaxoSmithKline plc Company Information
  21. 7.4.2 GlaxoSmithKline plc Business Overview
  22. 7.4.3 GlaxoSmithKline plc Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline plc Antimicrobial Therapeutics Product Portfolio
  24. 7.4.5 GlaxoSmithKline plc Recent Developments
  25. 7.5 Gilead Sciences, Inc.
  26. 7.5.1 Gilead Sciences, Inc. Company Information
  27. 7.5.2 Gilead Sciences, Inc. Business Overview
  28. 7.5.3 Gilead Sciences, Inc. Antimicrobial Therapeutics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Gilead Sciences, Inc. Antimicrobial Therapeutics Product Portfolio
  30. 7.5.5 Gilead Sciences, Inc. Recent Developments
8 North America
  1. 8.1 North America Antimicrobial Therapeutics Revenue (2021-2032)
  2. 8.2 North America Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 8.2.1 North America Antimicrobial Therapeutics Revenue by Type (2021-2026)
  4. 8.2.2 North America Antimicrobial Therapeutics Revenue by Type (2027-2032)
  5. 8.3 North America Antimicrobial Therapeutics Revenue Share by Type (2021-2032)
  6. 8.4 North America Antimicrobial Therapeutics Revenue by Application (2021-2032)
  7. 8.4.1 North America Antimicrobial Therapeutics Revenue by Application (2021-2026)
  8. 8.4.2 North America Antimicrobial Therapeutics Revenue by Application (2027-2032)
  9. 8.5 North America Antimicrobial Therapeutics Revenue Share by Application (2021-2032)
  10. 8.6 North America Antimicrobial Therapeutics Revenue by Country
  11. 8.6.1 North America Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Antimicrobial Therapeutics Revenue by Country (2021-2026)
  13. 8.6.3 North America Antimicrobial Therapeutics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Antimicrobial Therapeutics Revenue (2021-2032)
  2. 9.2 Europe Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 9.2.1 Europe Antimicrobial Therapeutics Revenue by Type (2021-2026)
  4. 9.2.2 Europe Antimicrobial Therapeutics Revenue by Type (2027-2032)
  5. 9.3 Europe Antimicrobial Therapeutics Revenue Share by Type (2021-2032)
  6. 9.4 Europe Antimicrobial Therapeutics Revenue by Application (2021-2032)
  7. 9.4.1 Europe Antimicrobial Therapeutics Revenue by Application (2021-2026)
  8. 9.4.2 Europe Antimicrobial Therapeutics Revenue by Application (2027-2032)
  9. 9.5 Europe Antimicrobial Therapeutics Revenue Share by Application (2021-2032)
  10. 9.6 Europe Antimicrobial Therapeutics Revenue by Country
  11. 9.6.1 Europe Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Antimicrobial Therapeutics Revenue by Country (2021-2026)
  13. 9.6.3 Europe Antimicrobial Therapeutics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Antimicrobial Therapeutics Revenue (2021-2032)
  2. 10.2 China Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 10.2.1 China Antimicrobial Therapeutics Revenue by Type (2021-2026)
  4. 10.2.2 China Antimicrobial Therapeutics Revenue by Type (2027-2032)
  5. 10.3 China Antimicrobial Therapeutics Revenue Share by Type (2021-2032)
  6. 10.4 China Antimicrobial Therapeutics Revenue by Application (2021-2032)
  7. 10.4.1 China Antimicrobial Therapeutics Revenue by Application (2021-2026)
  8. 10.4.2 China Antimicrobial Therapeutics Revenue by Application (2027-2032)
  9. 10.5 China Antimicrobial Therapeutics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antimicrobial Therapeutics Revenue (2021-2032)
  2. 11.2 Asia Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 11.2.1 Asia Antimicrobial Therapeutics Revenue by Type (2021-2026)
  4. 11.2.2 Asia Antimicrobial Therapeutics Revenue by Type (2027-2032)
  5. 11.3 Asia Antimicrobial Therapeutics Revenue Share by Type (2021-2032)
  6. 11.4 Asia Antimicrobial Therapeutics Revenue by Application (2021-2032)
  7. 11.4.1 Asia Antimicrobial Therapeutics Revenue by Application (2021-2026)
  8. 11.4.2 Asia Antimicrobial Therapeutics Revenue by Application (2027-2032)
  9. 11.5 Asia Antimicrobial Therapeutics Revenue Share by Application (2021-2032)
  10. 11.6 Asia Antimicrobial Therapeutics Revenue by Country
  11. 11.6.1 Asia Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Antimicrobial Therapeutics Revenue by Country (2021-2026)
  13. 11.6.3 Asia Antimicrobial Therapeutics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antimicrobial Therapeutics Revenue (2021-2032)
  2. 12.2 SAMEA Antimicrobial Therapeutics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Antimicrobial Therapeutics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Antimicrobial Therapeutics Revenue by Type (2027-2032)
  5. 12.3 SAMEA Antimicrobial Therapeutics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Antimicrobial Therapeutics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Antimicrobial Therapeutics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Antimicrobial Therapeutics Revenue by Application (2027-2032)
  9. 12.5 SAMEA Antimicrobial Therapeutics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Antimicrobial Therapeutics Revenue by Country
  11. 12.6.1 SAMEA Antimicrobial Therapeutics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Antimicrobial Therapeutics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Antimicrobial Therapeutics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst